Follow Us
© 2026 Arizent. All rights reserved.
For reprint and licensing requests for this article, click here.
As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.
As the scope of gene therapy grows, understanding their impact and cost can help organizations decide how to cover them through their healthcare plans.
Health outcomes, costs and time away from work are improved when a cancer strategy leads to evidence-based care.
